#United States #New York #Class Action #Shareholder Rights #Rocket Pharmaceuticals

Overview of the Legal Action Against Rocket Pharmaceuticals

The Gross Law Firm has recently announced an important update for shareholders of Rocket Pharmaceuticals, Inc. (NASDAQ: RCKT). If you purchased shares between February 27, 2025, and May 26, 2025, you have the opportunity to join a class action lawsuit against the company. The deadline to register for participation is August 11, 2025. This article provides detailed information about the case, the allegations, and the next steps for interested shareholders.

Allegations Against Rocket Pharmaceuticals

The legal complaint revolves around allegations that Rocket Pharmaceuticals provided overly optimistic statements regarding its clinical trials while knowingly concealing significant adverse information. Specifically, the lawsuit addresses issues relating to the clinical trial protocol for RP-A501, which the company is investigating for treating rare disease.

The complaint suggests that the company knowingly failed to inform investors about the serious risks associated with Serious Adverse Events (SAEs), including the death of patients enrolled in the study. In a notable amendment to the trial protocol, the introduction of a novel immunomodulatory agent was made without adequately disclosing this change to shareholders. This omission is seen as a breach of the company's responsibility to provide truthful and transparent information to investors.

Timeline of Events

• - February 27, 2025: The class period begins; shareholders purchase shares during this time.
• - May 23, 2025: Rocket's stock is trading at $6.27 per share.
• - May 27, 2025: Following Rocket's announcement of a clinical hold by the FDA due to a Serious Adverse Event, including a patient death, the stock plummets to $2.33, a dramatic 37% drop in just one session.

These events have prompted shareholders to consider taking legal action to recover losses incurred from the inflated stock prices caused by misleading statements.

Why Join the Class Action?

Joining the class action is a proactive way for shareholders to protect their investment rights. By participating, shareholders can be part of the recovery efforts against the company for potential losses incurred due to the alleged misconduct. Notably, you do not need to be appointed as a lead plaintiff to engage in the recovery process.

Once you register, you will be provided with portfolio monitoring software to track the status of the case and receive updates throughout its lifecycle. This transparent approach ensures that shareholders remain informed and engaged as the case progresses.

Next Steps for Interested Shareholders

To take part in the class action, it is crucial to act quickly. Shareholders need to register their information via the link provided by The Gross Law Firm. They will handle all the necessary legal proceedings and support you throughout the process. It’s important to note that registration is free, without any obligation or cost to participants.

For more information and to register, please visit this link.

Why Choose The Gross Law Firm?

The Gross Law Firm is a nationally recognized firm that specializes in class action cases, committed to fighting for the rights of affected investors. Their mission is to hold companies accountable for deceitful practices and ensure that they adhere to responsible business operations. They advocate on behalf of investors who have experienced loss due to false or misleading information disseminated by companies.

By aligning with seasoned legal practitioners at The Gross Law Firm, shareholders can navigate this complex legal landscape with confidence and clarity.

Contact Information

For any queries, shareholders may reach out to:

• - Address: 15 West 38th Street, 12th floor, New York, NY, 10018
• - Email: [email protected]
• - Phone: (646) 453-8903

Stay informed and involved as this case unfolds. By registering for the class action, you can take an important step in your journey toward justice and recovery against Rocket Pharmaceuticals.

Conclusion

The deadline for shareholders to join the class action against Rocket Pharmaceuticals is fast approaching. To ensure your rights are protected, it is crucial to register before August 11, 2025. Remember, participating in this class action could open the door to potential recovery for losses incurred due to the company's alleged wrongdoing. Don’t wait—take action today!